TrialDiabetes, obesity & metabolism2026

Evaluation of the Safety, Efficacy and Pharmacokinetics of BGM0504 in Chinese Adults With Type 2 Diabetes: A Multicentre, Randomised, Controlled and Double-Blind Phase II Trial.

Ping Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.